Clinical trial
Enteric Coated Myfortic for Liver Transplant Recipients
NCT00167492 · The University of Texas Health Science Center, Houston, Other · Withdrawn
Key facts
| NCT number | NCT00167492 |
|---|---|
| Title | Enteric Coated Myfortic for Liver Transplant Recipients |
| Official title | Enteric Coated Mycophenolic Acid (Myfortic) in Liver Transplant Recipients- Effect on Compliance and Calcineurin Inhibitor and Corticosteroid Sparing |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Collaborators | Novartis Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplantation |
| Intervention type | Drug |
| Interventions | Myfortic |
| Enrollment | 0 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Sep 14, 2005 |
| Last update posted | Dec 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: